Q1 2019 Holdings
Filed 2019-05-15 | 75 holdings | $4.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $1.2M | 13,351 | 27.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $808.0K | 9,099 | 18.0% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $729.0K | 6,190 | 16.2% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $409.0K | 22,309 | 9.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $324.0K | 4,806 | 7.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $322.0K | 11,981 | 7.2% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $307.0K | 2,112 | 6.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $272.0K | 25,284 | 6.1% |
| Ishares TR(IBB) | NASDAQ BIOTECH | 464287556 | $14.0K | 125,000 | 0.3% |
| Ishares TR(IBB)Call | NASDAQ BIOTECH | 464287556 | $9.5K | 85,000 | 0.2% |
| Direxion SHS ETF TR(LABUUSD) | SP BIOTCH BL NEW | 25490K323 | $5.9K | 98,011 | 0.1% |
| Mettler Toledo International(MTD) | COM | 592688105 | $2.3K | 3,235 | 0.1% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $1.9K | 138,461 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $1.6K | 20,124 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $1.6K | 33,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $1.5K | 8,074 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $1.5K | 4,675 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $1.3K | 9,927 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $1.3K | 17,832 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $1.2K | 62,575 | 0.0% |
| Qiagen NV(QGEN) | SHS NEW | N72482123 | $1.2K | 28,858 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $1.1K | 9,699 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $919 | 5,840 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $913 | 10,613 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $904 | 2,201 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $848 | 14,215 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $803 | 8,510 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $783 | 26,936 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $677 | 17,339 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $644 | 5,756 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $624 | 50,378 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $619 | 3,674 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $559 | 10,852 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $543 | 6,780 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $541 | 30,075 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $535 | 9,725 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $528 | 6,093 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $506 | 8,832 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $502 | 9,479 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $500 | 36,731 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $487 | 28,490 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $482 | 48,485 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $472 | 13,214 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $447 | 6,116 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $447 | 3,570 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $438 | 9,770 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $432 | 18,631 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $428 | 11,250 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $417 | 234,030 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $408 | 11,648 | 0.0% |